etoposide has been researched along with lycopene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhuri, T; Das, D; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Wyatt, MD | 1 |
| Amiri, M; Kiani, A; Mohammadzadeh, S | 1 |
2 other study(ies) available for etoposide and lycopene
| Article | Year |
|---|---|
Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Topics: Adenomatous Polyposis Coli Protein; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Blotting, Western; Breast Neoplasms; Carotenoids; Cell Cycle; Cell Proliferation; Comet Assay; Cyclin D1; Drug Synergism; Etoposide; Female; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lycopene; Promoter Regions, Genetic; Quinacrine; RNA, Small Interfering; Signal Transduction; T Cell Transcription Factor 1; TCF Transcription Factors; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Wnt Proteins | 2013 |
Lycopene modulates hepatic toxicity and testicular injury induced by etoposide in male rats.
Topics: Animals; Cholesterol, LDL; Etoposide; Hepatitis; Humans; Lycopene; Male; Rats; Rats, Wistar; Testicular Diseases; Testosterone | 2023 |